What we know about the Covid variant EG.5 dubbed 'Eris'
The World Health Organisation declared the variant of interest, with cases reported in 51 countries.
Similar Posts
Cancer causes: These 10 hidden carcinogens can raise the risk, according to an oncology expert
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Covid Inquiry: What have we learnt so far?
The first phase of the Covid Inquiry has come to an end. What have we learnt over the past six weeks?
Who had it good — and who had it bad — in 2023
Curtis S. Chin, a former U.S. ambassador to the Asian Development Bank, is managing director of advisory firm RiverPeak Group. Jose B. Collazo is an analyst focusing on the Indo-Pacific region. Follow them on X at @CurtisSChin and @JoseBCollazo. As 2023 comes to a close, we take a look at the year that was in…
Bullying 'normal occurrence' at Newcastle NHS trust, say CQC
Newcastle Hospitals NHS Foundation Trust’s CQC rating is downgraded to “requires improvement”.
Whistleblowers accuse NHS trust of avoidable baby deaths
Serious concerns are raised over maternity services at Gloucestershire Hospitals NHS Trust.
These 4 anti-obesity drug stocks could soar, Berenberg says
The anti-obesity drug market is expected to remain in focus this year after a bumper 2023 for weight loss drugmakers Novo Nordisk and Eli Lilly , according to Berenberg. The Germany-headquartered investment bank expects a combination of new clinical data, and the expiry of Novo ‘s patent for the active ingredient in first-generation GLP-1 drugs,…